|
1
|
Bailey E and Kroshinsky D: Cellulitis:
diagnosis and management. Dermatol Ther. 24:229–239. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Muileboom J, Hamilton M and Kelly L: The
changing face of cellulitis and MRSA in rural Canada: a clinical
update. Can J Rural Med. 18:137–139. 2013.PubMed/NCBI
|
|
3
|
Stevens DL, Bisno AL, Chambers HF,
Dellinger EP, Goldstein EJC, Gorbach SL, Hirschmann JV, Kaplan SL,
Montoya JG and Wade JC: Practice guidelines for the diagnosis and
management of skin and soft tissue infections: 2014 update by the
Infectious Diseases Society of America. Clin Infect Dis.
59:e10–e52. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Szalowska E, Elferink MGL, Hoek A,
Groothuis GMM and Vonk RJ: Resistin is more abundant in liver than
adipose tissue and is not up-regulated by lipopolysaccharide. J
Clin Endocrinol Metab. 94:3051–3057. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gan AM, Butoi ED, Manea A, Simion V, Stan
D, Parvulescu MM, Calin M, Manduteanu I and Simionescu M:
Inflammatory effects of resistin on human smooth muscle cells:
up-regulation of fractalkine and its receptor, CX3CR1 expression by
TLR4 and Gi-protein pathways. Cell Tissue Res. 351:161–174. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Durazzo M, Belci P, Niro G, et al:
Variations of serum levels of adiponectin and resistin in chronic
viral hepatitis. J Endocrinol Invest. 36:600–605. 2013.PubMed/NCBI
|
|
7
|
Vassiliadi DA, Tzanela M, Kotanidou A,
Orfanos SE, Nikitas N, Armaganidis A, Koutsilieris M, Roussos C,
Tsagarakis S and Dimopoulou I: Serial changes in adiponectin and
resistin in critically ill patients with sepsis: associations with
sepsis phase, severity, and circulating cytokine levels. J Crit
Care. 27:400–409. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cekmez F, Canpolat FE, Cetinkaya M,
Aydinöz S, Aydemir G, Karademir F, Ipcioglu OM and Sarici SÜ:
Diagnostic value of resistin and visfatin, in comparison with
C-reactive protein, procalcitonin and interleukin-6 in neonatal
sepsis. Eur Cytokine Netw. 22:113–117. 2011.PubMed/NCBI
|
|
9
|
Gerber PA, Thalhammer C, Schmied C, Spring
S, Amann-Vesti B, Spinas GA and Berneis K: Small, dense LDL
particles predict changes in intima media thickness and insulin
resistance in men with type 2 diabetes and prediabetes – a
prospective cohort study. PLoS One. 8:e727632013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Makni E, Moalla W, Benezzeddine-Boussaidi
L, Lac G, Tabka Z and Elloumi M: Correlation of resistin with
inflammatory and cardiometabolic markers in obese adolescents with
and without metabolic syndrome. Obes Facts. 6:393–404. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Puel A, Picard C, Lorrot M, Pons C,
Chrabieh M, Lorenzo L, Mamani-Matsuda M, Jouanguy E, Gendrel D and
Casanova JL: Recurrent staphylococcal cellulitis and subcutaneous
abscesses in a child with autoantibodies against IL-6. J Immunol.
180:647–654. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gruzdeva O, Uchasova E, Dyleva Y, Belik E,
Shurygina E and Barbarash O: Insulin resistance and inflammation
markers in myocardial infarction. J Inflamm Res. 6:83–90.
2013.PubMed/NCBI
|
|
13
|
Karppelin M, Siljander T, Aittoniemi J,
Hurme M, Huttunen R, Huhtala H, Kere J, Vuopio J and Syrjänen J:
Predictors of recurrent cellulitis in five years. Clinical risk
factors and the role of PTX3 and CRP. J Infect. Nov 15–2014.(Epub
ahead of print). PubMed/NCBI
|
|
14
|
Kitanovski L, Jazbec J, Hojker S and
Derganc M: Diagnostic accuracy of lipopolysaccharide-binding
protein for predicting bacteremia/clinical sepsis in children with
febrile neutropenia: comparison with interleukin-6, procalcitonin,
and C-reactive protein. Support Care Cancer. 22:269–277. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park HK, Qatanani M, Briggs ER, Ahima RS
and Lazar MA: Inflammatory induction of human resistin causes
insulin resistance in endotoxemic mice. Diabetes. 60:775–783. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sakr Y, Sponholz C, Tuche F, Brunkhorst F
and Reinhart K: The role of procalcitonin in febrile neutropenic
patients: review of the literature. Infection. 36:396–407. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hirschmann JV and Raugi GJ: Lower limb
cellulitis and its mimics: part I. Lower limb cellulitis. J Am Acad
Dermatol. 67:e1–e12. 2012. View Article : Google Scholar
|
|
18
|
Maze MJ, Skea S, Pithie A, Metcalf S,
Pearson JF and Chambers ST: Prevalence of concurrent deep vein
thrombosis in patients with lower limb cellulitis: a prospective
cohort study. BMC Infect Dis. 13:1412013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Stevens DL, Bisno AL, Chambers HF, et al:
Infectious Diseases Society of America: Practice guidelines for the
diagnosis and management of skin and soft-tissue infections. Clin
Infect Dis. 41:1373–1406. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
May AK, Stafford RE, Bulger EM, Heffernan
D, Guillamondegui O, Bochicchio G and Eachempati SR: Surgical
Infection Society: Treatment of complicated skin and soft tissue
infections. Surg Infect (Larchmt). 10:467–499. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Matthews DR, Hosker JP, Rudenski AS,
Naylor BA, Treacher DF and Turner RC: Homeostasis model assessment:
insulin resistance and beta-cell function from fasting plasma
glucose and insulin concentrations in man. Diabetologia.
28:412–419. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fadda SM, Gamal SM, Elsaid NY and Mohy AM:
Resistin in inflammatory and degenerative rheumatologic diseases.
Relationship between resistin and rheumatoid arthritis disease
progression. Z Rheumatol. 72:594–600. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Aliefendioglu D, Gürsoy T, Çağlayan O,
Aktaş A and Ovalı F: Can resistin be a new indicator of neonatal
sepsis? Pediatr Neonatol. 55:53–57. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gokmen Z, Ozkiraz S, Kulaksizoglu S,
Kilicdag H, Ozel D, Ecevit A and Tarcan A: Resistin – a novel
feature in the diagnosis of sepsis in premature neonates. Am J
Perinatol. 30:513–517. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tanaka N, Kusunoki N, Kusunoki Y, Hasunuma
T and Kawai S: Resistin is associated with the inflammation process
in patients with systemic autoimmune diseases undergoing
glucocorticoid therapy: comparison with leptin and adiponectin. Mod
Rheumatol. 23:8–18. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
PubMed PMID: 22434063, . Bokarewa M,
Nagaev I, Dahlberg L, Smith U and Tarkowski A: Resistin, an
adipokine with potent proinflammatory properties. J Immunol.
174:5789–5795. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
de Luis DA, González Sagrado M, Conde R,
Aller R, Izaola O and Castro MJ: Circulating adipocytokines in
morbid obese patients, relation with cardiovascular risk factors
and anthropometric parameters. Nutr Hosp. 26:91–96. 2011.PubMed/NCBI
|
|
28
|
Stofkova A: Resistin and visfatin:
regulators of insulin sensitivity, inflammation and immunity.
Endocr Regul. 44:25–36. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yoshino T, Kusunoki N, Tanaka N, Kaneko K,
Kusunoki Y, Endo H, Hasunuma T and Kawai S: Elevated serum levels
of resistin, leptin, and adiponectin are associated with C-reactive
protein and also other clinical conditions in rheumatoid arthritis.
Intern Med. 50:269–275. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen BH, Song Y, Ding EL, Roberts CK,
Manson JE, Rifai N, Buring JE, Gaziano JM and Liu S: Circulating
levels of resistin and risk of type 2 diabetes in men and women:
results from two prospective cohorts. Diabetes Care. 32:329–334.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Breyer MK, Rutten EP, Vernooy JH, Spruit
MA, Dentener MA, van der Kallen C, van Greevenbroek MM and Wouters
EF: Gender differences in the adipose secretome system in chronic
obstructive pulmonary disease (COPD): a pivotal role of leptin.
Respir Med. 105:1046–1053. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sachs MK: Cutaneous cellulitis. Arch
Dermatol. 127:493–496. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rull A, Camps J, Alonso-Villaverde C and
Joven J: Insulin resistance, inflammation, and obesity: role of
monocyte chemoattractant protein-1 (or CCL2) in the regulation of
metabolism. Mediators Inflamm. 2010:3265802010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Goktas Z, Moustaid-Moussa N, Shen CL,
Boylan M, Mo H and Wang S: Effects of bariatric surgery on
adipokine-induced inflammation and insulin resistance. Front
Endocrinol (Lausanne). 4:692013.PubMed/NCBI
|
|
35
|
Fernández-Veledo S, Nieto-Vazquez I,
Vila-Bedmar R, Garcia-Guerra L, Alonso-Chamorro M and Lorenzo M:
Molecular mechanisms involved in obesity-associated insulin
resistance: therapeutical approach. Arch Physiol Biochem.
115:227–239. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou M, Wu R, Dong W, Jacob A and Wang P:
Endotoxin downregulates peroxisome proliferator-activated
receptor-gamma via the increase in TNF-alpha release. Am J Physiol
Regul Integr Comp Physiol. 294:R84–R92. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang Z and Nakayama T: Inflammation, a
link between obesity and cardiovascular disease. Mediators Inflamm.
2010:5359182010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kones R: Rosuvastatin, inflammation,
C-reactive protein, JUPITER, and primary prevention of
cardiovascular disease – a perspective. Drug Des Devel Ther.
4:383–413. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pfützner A and Forst T: High-sensitivity
C-reactive protein as cardiovascular risk marker in patients with
diabetes mellitus. Diabetes Technol Ther. 8:28–36. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Choi SH, Hong ES and Lim S: Clinical
implications of adipocytokines and newly emerging metabolic factors
with relation to insulin resistance and cardiovascular health.
Front Endocrinol (Lausanne). 4:972013.PubMed/NCBI
|
|
41
|
Jankiewicz-Wika J, Kołomecki K, Cywiński
J, Piestrzeniewicz K, Swiętosławski J, Stępień H and Komorowski J:
Impact of vertical banded gastroplasty on body weight, insulin
resistance, adipocytokine, inflammation and metabolic syndrome
markers in morbidly obese patients. Endokrynol Pol. 62:109–119.
2011.PubMed/NCBI
|
|
42
|
Zeyda M and Stulnig TM: Obesity,
inflammation, and insulin resistance – a mini-review. Gerontology.
55:379–386. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kumar R, Prakash S, Chhabra S, Singla V,
Madan K, Gupta SD, Panda SK, Khanal S and Acharya SK: Association
of pro-inflammatory cytokines, adipokines & oxidative stress
with insulin resistance & non-alcoholic fatty liver disease.
Indian J Med Res. 136:229–236. 2012.PubMed/NCBI
|
